Table 9

Hematologic values of polo horses with glanders during the study period
Treatment period (n = 23) Post treatment observation period (n = 17)
Parameters d 0 d 84 d 180 d 240 d 360
RBC count (1012/1) 3.94 ± 0.78 6.30 ± 0.4 6.80 ± 0.37 7.053 ± 0.29 6.957 ± 0.36
WBC count (109/1) 19.15 ± 4.11 8.10 ± 0.79 7.91 ± 1.23 7.97 ± 2.14 7.52 ± 1.12
Hb [g/dL] 7.918 ± 1.7 11.94 ± 0.69 12.79 ± 1.1 13.58 ± 1.0 13.13 ± 1.2
PCV (ratio) 0.25 ± 0.047 0.38 ± 0.015 0.41 ± 0.028 0.39 ± 0.025 0.38 ± 0.0 12
ESR (mm/20 min) 126.83 ± 10.40 25.15 ± 2.6 21.42 ± 1.94 23.19 ± 2.41 19.89 ± 3.15
Differential Leukocyte Count
Neutrophils (%) 73.06 ± 9.12 51.0 ± 9.12 50.3 ± 4.39 53.2 ± 3.14 57.28 ± 0.89
Lymphocytes (%) 21.69 ± 6.95 39.7 ± 3.91 47.1 ± 3.01 43.01 ± 2.10 37.5 ± 1.23
Eosinophils (%) 4.77 ± 2.16 3.11 ± 0.57 2.12 ± 0.76 2.190 ± 0.911 4.23 ± 2.11
Monocytes (%) 1.69 ± 1.02 1.52 ± 0.89 1.76 ± 1.40 2.140 ± 1.024 1.2 ± 1.00
Basophils (%) - - - - -

Saqib et al.

Saqib et al. BMC Veterinary Research 2012 8:214   doi:10.1186/1746-6148-8-214

Open Data